deferoxamine has been researched along with Cancer of Nasopharynx in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yeung, HY | 1 |
Lai, KP | 1 |
Chan, HY | 1 |
Mak, NK | 1 |
Wagner, GF | 1 |
Wong, CK | 1 |
Mathias, CJ | 1 |
Wang, S | 1 |
Lee, RJ | 1 |
Waters, DJ | 1 |
Low, PS | 1 |
Green, MA | 1 |
2 other studies available for deferoxamine and Cancer of Nasopharynx
Article | Year |
---|---|
Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells.
Topics: Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Female; Ferric Compounds; Ferricyanides; Glycopro | 2005 |
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Topics: Animals; Carrier Proteins; Deferoxamine; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Ma | 1996 |